What is AEMD stock price today?

AEMD (Aethlon Medical Inc) stock is trading at $2.70 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is AEMD stock going up or down today?

AEMD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AEMD stock now?

The decision to buy AEMD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AEMD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AEMD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AEMD stock overvalued or undervalued?

AEMD currently trades at a P/E ratio of 0.01, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if AEMD is fairly priced.

What is AEMD's P/E ratio?

AEMD has a price-to-earnings (P/E) ratio of 0.01, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is AEMD's market cap?

AEMD (Aethlon Medical Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is AEMD's price to book ratio?

AEMD trades at a price-to-book (P/B) ratio of 0.49, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does AEMD pay dividends?

AEMD does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is AEMD's dividend yield?

AEMD does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is AEMD stock a good long-term investment?

AEMD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is AEMD's revenue growth rate?

AEMD has shown revenue growth of 42.8% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for AEMD are available on our dashboard with complete income statement analysis.

What are the risks of investing in AEMD?

Key risks for AEMD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does AEMD compare to its competitors?

Compare AEMD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize AEMD's performance and positioning.

What is AEMD's stock price target for 2026?

Our AI model provides price targets for AEMD based on fundamental analysis: Bull case $3.51 (+30%), Base case $3.10 (+15%), Bear case $2.43 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about AEMD?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for AEMD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is AEMD's next earnings report?

AEMD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

AEMD - Aethlon Medical Inc

NYSE * Health Care * Health Care Equipment & Supplies

$2.70

$-0.22 (-7.53%)

About Aethlon Medical Inc

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

AEMD Key Statistics

Market Cap

$2.63M

P/E Ratio

0.01

P/B Ratio

0.49

EPS

$209.20

Revenue Growth

+42.8%

Employees

How AEMD Compares to Peers

AEMD has the lowest P/E ratio in Health Care Equipment & Supplies, suggesting it may be the most undervalued

AEMD has the fastest revenue growth among competitors

AEMD is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
AEMD(This stock)	$2.63M	0.0	43%	0.0%	-
AAPLApple Inc	$3.66T	33.1	0%	0.3%	vs AAPL
MSFTMicrosoft Corp	$3.38T	36.3	15%	0.4%	vs MSFT
GOOGLAlphabet Inc	$3.89T	23.1	14%	0.3%	vs GOOGL
AMZNAmazon Com	$2.47T	32.7	0%	0.1%	vs AMZN
NVDANvidia Corp	$4.33T	44.1	1%	0.5%	vs NVDA

Aethlon Medical Inc Company Information

Headquarters: California; U.S.A
Website: www.aethlonmedical.com
Sector: Health Care
Industry: Health Care Equipment & Supplies

Data Updated: January 21, 2026 at 3:42 AM EST

Ready to invest in AEMD?

Commission-free trading available. Affiliate links.

AEMD Lician Score

5% confidence

4.0/10

Neutral

AEMD has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates AEMDacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

AEMD Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for AEMD

Dashboard

Enter a ticker to analyze